Pangaea Oncology, S.A. (PANG.MC)

EUR 1.68

(0.0%)

Net Debt Summary of Pangaea Oncology, S.A.

Pangaea Oncology, S.A.'s latest annual net debt in 2023 was 4.34 Million EUR , up 220.39% from previous year.
Pangaea Oncology, S.A.'s latest quarterly net debt in 2023 FY was 4.34 Million EUR , up 220.39% from previous quarter.
Pangaea Oncology, S.A. reported annual net debt of -3.61 Million EUR in 2022, down -208.23% from previous year.
Pangaea Oncology, S.A. reported annual net debt of 3.33 Million EUR in 2021, down -48.63% from previous year.
Pangaea Oncology, S.A. reported quarterly net debt of -1.18 Million EUR for 2023 Q1, up 67.07% from previous quarter.
Pangaea Oncology, S.A. reported quarterly net debt of -134.68 Thousand EUR for 2023 Q2, up 88.67% from previous quarter.

Annual Net Debt Chart of Pangaea Oncology, S.A. (2023 - 2013)

Historical Annual Net Debt of Pangaea Oncology, S.A. (2023 - 2013)

Year	Net Debt	Net Debt Growth
2023	4.34 Million EUR	220.39%
2022	-3.61 Million EUR	-208.23%
2021	3.33 Million EUR	-48.63%
2020	6.49 Million EUR	91.83%
2019	3.38 Million EUR	-17.21%
2018	4.08 Million EUR	-65.71%
2017	11.92 Million EUR	5597.56%
2016	-216.91 Thousand EUR	-107.0%
2015	3.09 Million EUR	27.35%
2014	2.43 Million EUR	380.79%
2013	505.94 Thousand EUR	0.0%

Year	Net Debt	Net Debt Growth
2023 FY	4.34 Million EUR	220.39%
2023 Q1	-1.18 Million EUR	67.07%
2023 Q2	-134.68 Thousand EUR	88.67%
2023 Q4	4.34 Million EUR	117.24%
2023 Q3	2 Million EUR	1585.64%
2022 Q4	-3.61 Million EUR	0.0%
2022 FY	-3.61 Million EUR	-208.23%
2022 Q2	-7.71 Million EUR	0.0%
2021 FY	3.33 Million EUR	-48.63%
2021 Q4	3.33 Million EUR	0.0%
2021 Q2	2.12 Million EUR	0.0%
2020 Q2	4.33 Million EUR	0.0%
2020 FY	6.49 Million EUR	91.83%
2020 Q4	6.49 Million EUR	0.0%
2019 Q4	3.38 Million EUR	0.0%
2019 FY	3.38 Million EUR	-17.21%
2019 Q2	4.25 Million EUR	0.0%
2018 Q4	4.08 Million EUR	0.0%
2018 Q2	10.58 Million EUR	0.0%
2018 FY	4.08 Million EUR	-65.71%
2017 FY	11.92 Million EUR	5597.56%
2017 Q4	11.92 Million EUR	0.0%
2017 Q2	3.26 Million EUR	0.0%
2016 Q2	3.17 Million EUR	0.0%
2016 FY	-216.91 Thousand EUR	-107.0%
2016 Q4	-216.91 Thousand EUR	0.0%
2015 Q4	3.09 Million EUR	0.0%
2015 FY	3.09 Million EUR	27.35%
2014 FY	2.43 Million EUR	380.79%
2013 FY	505.94 Thousand EUR	0.0%

Peer Net Debt Comparison of Pangaea Oncology, S.A.

Name	Net Debt	Net Debt Difference
Clínica Baviera, S.A.	38.96 Million EUR	88.844%